Anabelle Colaco
22 Aug 2026, 09:30 GMT+10
CAMBRIDGE, Massachusetts: Moderna shares more than doubled on August 19 after the company reported initial results from a study of an experimental personalized mRNA cancer treatment that would be the first of its kind if approved by regulators.
Moderna and Merck are developing the treatment using an mRNA-based cancer vaccine called intismeran, which is designed to be tailored to individual patients based on unique mutations within their tumors.
In current studies, the companies are pairing intismeran with Keytruda, an immunotherapy drug made by Merck.
The study compared intismeran and Keytruda together in melanoma patients with Keytruda alone.
The companies said patients who received the combination treatment lived longer without their cancer returning or metastasizing than patients who received Keytruda alone.
Moderna and Merck did not disclose how long patients survived without their cancer returning. They also did not say whether patients receiving the combination treatment lived longer overall.
The companies said they plan to present the study results at an upcoming international medical meeting.
Moderna shares climbed more than 120 percent to US$140.12 a share following the announcement, while Merck shares rose about 11 percent.
Get a daily dose of Milwaukee Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Milwaukee Sun.
More InformationJERUSALEM/CAIRO: More than two years after her killing, Israel's military admitted that its troops had opened fire on a car carrying...
HONG KONG/SHENZHEN, China: The founder of China Evergrande Group, the world's most heavily indebted property developer, was sentenced...
KYIV, Ukraine: A major Russian airstrike killed 16 people and injured more than 40 in Kyiv and the surrounding region on August 20....
WASHINGTON D.C.: U.S. public debt has crossed US$40 trillion for the first time, more than doubling in less than a decade as government...
OAKLAND, California: A former Meta Platforms engineering director told jurors on Thursday that CEO Mark Zuckerberg fostered a company...
DAMASCUS, Syria: Syrian security forces have arrested a former security officer from the Assad era who fled Austria after being sentenced...
WASHINGTON, DC: The U.S. Federal Trade Commission is investigating healthcare database giant Epic Systems over how it grants or restricts...
(Photo credit: Benny Sieu-Imagn Images) Jacob Misiorowski pitched six shutout innings and outdueled Chris Sale in a matchup of National...
(Photo credit: Jayne Kamin-Oncea-Imagn Images) Although Los Angeles Dodgers owner Mark Walter is selling off other holdings while...
(Photo credit: Charles LeClaire-Imagn Images) Geno Smith made the most of his lone drive, completing all of his passes and throwing...
(Photo credit: Benny Sieu-Imagn Images) Jacob Misiorowski pitched six shutout innings and outdueled Chris Sale in a matchup of Cy...
(Photo credit: Kevin Jairaj-Imagn Images) Klay Thompson is close to joining the Miami Heat after having the final year of his contract...
